Change in Echocardiographic Parameters in Patients Receiving a Quadruple Ultra-Low-Dose Anti-Hypertensive Combination for Treatment of Hypertension

This group has previously demonstrated greater blood pressure (BP)-lowering effects using a quadruple ultra-low-dose combination of anti-hypertensives (irbesartan 37.5 mg, amlodipine 1.25 mg, indapamide 0.625 mg, bisoprolol 2.5 mg) ( “quadpill”) compared with standard monotherapy (irbesartan 150 mg). It sought to compare changes in echocardiographic parameters between the two groups after 12 months of treatment.

https://www.heartlungcirc.org/article/S1443-9506(23)02842-1/fulltext?rss=yes

Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: P. Emerson, M. Schlaich, A. Rajwani, C. Chow, G. Hillis, L. Thomas Source Type: research